A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2004
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1550504A Process of high purity albumin production
12/01/2004	CN1550234A Hair-growing agent composition
12/01/2004	CN1177860C Cholenic acid amides and pharmaceutical compositions thereof
12/01/2004	CN1177844C Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177830C Benzoheterocycles and their use as MEK inhibitors
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177615C Arteriovenous and venous graft treatment methods and compsns.
12/01/2004	CN1177602C Traditional Chinese medicine composition for curing acne
12/01/2004	CN1177601C Medicine for treating scald and its preparing method
12/01/2004	CN1177599C Chinese medicine for treating burn and scald and its preparing process
12/01/2004	CN1177594C Formulation for use in prevention of pathogen induced diseases including HIV and HSV
12/01/2004	CN1177591C Medicaments that contain xenogenic oligo-or/and polyribonucleotides
12/01/2004	CN1177580C Phytosterol copmositions and their application
11/2004
11/30/2004	US6825360 Bicyclic aromatic compounds
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825233 Substituted bonzoic acid derivatives, useful for preventing and/or treating tumors, arthritis, and non-malignant skin disorders
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825219 Substituted benzimidazole compounds
11/30/2004	US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004	US6825207 Anticancer agents
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	US6825180 Cytokine intracellular signaling inhibitors; antiinflammatory agents
11/30/2004	US6825179 Active ingredient combinations or adducts of cyclodextrins and quinones
11/30/2004	US6825008 Expressed ligand—vascular intercellular signalling molecule
11/30/2004	US6824978 Regulation of endogenous gene expression in cells using zinc finger proteins
11/30/2004	US6824786 Topical applying cosmetic
11/30/2004	US6824773 TWEAK receptor
11/25/2004	WO2004101775A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	WO2004101609A2 Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing
11/25/2004	WO2004101514A1 Cyanofluoropyrrolidine derivative
11/25/2004	WO2004100982A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100962A1 Melanogenesis inhibitory substance
11/25/2004	WO2004100934A1 Insoluble globin injectable implant
11/25/2004	WO2004100923A1 The composition for external use by percutaneous administration
11/25/2004	WO2004100909A1 Cosmetic and/or dermatological preparations containing an extract from the seeds of plants of the genus adenanthera
11/25/2004	WO2004100861A2 Pharmaceutical composition comprising lectin
11/25/2004	WO2004091639A3 Lipid extract from fruit of low lipid content
11/25/2004	WO2004087170B1 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease
11/25/2004	WO2004087167A3 Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
11/25/2004	WO2003101945A8 Ligands that are inhibitors of the rar receptors
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	WO2002102371A9 Use of ascorbic acid for producing topical preparations with angiogenetic effects
11/25/2004	US20040236147 Integrin antagonist; antiinflammatory agents; antiarthritic agents; inflammatory bowel disease; lupus; multiple sclerosis; asthma; psoriasis;antidiabetic agents; cardiovascular disorders
11/25/2004	US20040236116 Novel bicyclic and tricyclic cannabinoids
11/25/2004	US20040236111 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/25/2004	US20040236108 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO); treat an inflammatory disease or condition, related to carbohydrate metabolism, smooth muscle cell function; chemical synthesis
11/25/2004	US20040236105 Triazole derivatives useful in therapy
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004	US20040236098 Tocopheryl retinyl succinate, tocopheryl cholecalciferyl succinate or tocopheryl ascorbyl succinate; sustained releasing active agents or vitamin by hydrolyzing with esterase contained in the skin; dermatology, cosmetics
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235955 Remedies for pruritus
11/25/2004	US20040235950 Administering, topically or systemically, an inhibitor of the matrix degrading enzymes and a cytokine inhibitor that alleviates inflammation and also alleviate neutrophil infiltration
11/25/2004	US20040235944 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions
11/25/2004	US20040235938 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235917 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235890 Remedies for allergic diseases
11/25/2004	US20040235876 4,5-Disubstituted-2-aminopyrimidines
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235868 Purine derivatives having, in particular, anti-proliferative properties and their biological uses
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/25/2004	US20040235837 Method for treating fibrotic diseases or other indications IE
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease.
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235719 Reacting a first aliquot of the protein with a heterobifunctional coupling agent; and reacting the product with a second aliquot of the protein wherein the coupling reagent contains groups reactive to thiol groups and groups reactive to amine groups
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040234632 Use of oil from seeds of gourd family members chosen from Lagenaria, Luffa, and Momordica for preparing composition to inhibit 5a-reductase activity; for treatment of prostatic hypertrophy, prostatic adenoma, acne, hyperseborrhea, alopecia and hirsutism
11/25/2004	US20040234614 Chitin microparticles and their medical uses
11/25/2004	US20040234592 Mixture containing thyroid hormone , ethanolamine and emulsifier
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234481 Gene transfers of angiogenic factor for skin disease
11/25/2004	US20040234474 mixture of silicone fluid , silica and drug; wound dressing; topical applying; drug delivery
11/25/2004	US20040234464 Photoprotective cosmetic compositions comprising para-aminobenzalmalonate-substituted s-triazine compounds
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525909A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	CA2525522A1 C1 inhibitor with short half-life for transient treatment
11/25/2004	CA2525465A1 Topical composition for transdermal administration
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2525049A1 Insoluble globin injectable implant
11/24/2004	EP1479684A1 Thienopyrimidines, process for preparing the same and use thereof
11/24/2004	EP1479386A1 Use of isoquinoline-derivatives for treating and preventing pigmentary disorders

1 ... 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 ... 1065